Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Blood Cancer Journal|December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemiaFarhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Haematologica|August 10, 2023
<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseasesAnna Carbo-Meix, Francesca Guijarro, Luojun Wang, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Nature Genetics|November 13, 2012
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingJulia Richter, Matthias Schlesner, Steve Hoffmann, et al.
Blood|April 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variantClive S Zent, Enrico Tiacci, Robert J Kreitman, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Leukemia|January 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Blood Cancer Journal|December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemiaFarhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Haematologica|August 10, 2023
<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseasesAnna Carbo-Meix, Francesca Guijarro, Luojun Wang, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Nature Genetics|November 13, 2012
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingJulia Richter, Matthias Schlesner, Steve Hoffmann, et al.
Blood|April 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variantClive S Zent, Enrico Tiacci, Robert J Kreitman, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Leukemia|January 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, et al.
Pageof 19